Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Journal of Cellular Biochemistry
|
May 19, 2018
Cytokines and chemokines differentially regulate innate immune cell trafficking during post kala-azar dermal leishmaniasis
Ashish K Singh, Vidya N R Das, Ajay Amit, et al.
Journal of Vector Borne Diseases
|
December 3, 2020
Magnitude of unreported kala-azar cases in a highly endemic district of Bihar, India: A positive impact of Indian elimination programme
N A Siddiqui, K Pandey, V N R Das, et al.
Cytokine
|
July 14, 2018
Visceral leishmaniasis: A novel nuclear envelope protein 'nucleoporins-93 (NUP-93)' from Leishmania donovani prompts macrophage signaling for T-cell activation towards host protective immune response
Manish K Singh, Fauzia Jamal, Amit K Dubey, et al.
The Journal of Infection
|
November 5, 2005
Visceral leishmaniasis (kala-azar)--the Bihar (India) perspective
P K Sinha, A Ranjan, V P Singh, et al.
Human Immunology
|
August 27, 2013
Leishmania donovani: influence of anti-leishmanial therapy on expression of lymphocyte function-associated antigen-3 and its relevance to pathogenisis in visceral leishmaniasis
Pushkar Shivam, Fauzia Jamal, Sarita Kumari, et al.
Cytokine
|
February 21, 2015
Leishmania donovani skews the CD56(+) Natural Killer T cell response during human visceral leishmaniasis
Sarita Kumari, Fauzia Jamal, Pushkar Shivam, et al.
Cellular Immunology
|
April 16, 2014
Evaluation of Leishmania donovani disulfide isomerase as a potential target of cellular immunity against visceral leishmaniasis
Ajay Amit, Rajesh Chaudhary, Anupam Yadav, et al.
Experimental Parasitology
|
May 15, 2012
Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection
Sanjiva Bimal, Sukrat Sinha, Shubhankar K Singh, et al.
Tropical Medicine & International Health : TM & IH
|
November 10, 2012
Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial
Shyam Sundar, Prabat Sinha, T K Jha, et al.
Frontiers in Immunology
|
January 10, 2018
Identification of Potential MHC Class-II-Restricted Epitopes Derived from <i>Leishmania donovani</i> Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis
Manas Ranjan Dikhit, Akhilesh Kumar, Sushmita Das, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Journal of Cellular Biochemistry
|
May 19, 2018
Cytokines and chemokines differentially regulate innate immune cell trafficking during post kala-azar dermal leishmaniasis
Ashish K Singh, Vidya N R Das, Ajay Amit, et al.
Journal of Vector Borne Diseases
|
December 3, 2020
Magnitude of unreported kala-azar cases in a highly endemic district of Bihar, India: A positive impact of Indian elimination programme
N A Siddiqui, K Pandey, V N R Das, et al.
Cytokine
|
July 14, 2018
Visceral leishmaniasis: A novel nuclear envelope protein 'nucleoporins-93 (NUP-93)' from Leishmania donovani prompts macrophage signaling for T-cell activation towards host protective immune response
Manish K Singh, Fauzia Jamal, Amit K Dubey, et al.
The Journal of Infection
|
November 5, 2005
Visceral leishmaniasis (kala-azar)--the Bihar (India) perspective
P K Sinha, A Ranjan, V P Singh, et al.
Human Immunology
|
August 27, 2013
Leishmania donovani: influence of anti-leishmanial therapy on expression of lymphocyte function-associated antigen-3 and its relevance to pathogenisis in visceral leishmaniasis
Pushkar Shivam, Fauzia Jamal, Sarita Kumari, et al.
Cytokine
|
February 21, 2015
Leishmania donovani skews the CD56(+) Natural Killer T cell response during human visceral leishmaniasis
Sarita Kumari, Fauzia Jamal, Pushkar Shivam, et al.
Cellular Immunology
|
April 16, 2014
Evaluation of Leishmania donovani disulfide isomerase as a potential target of cellular immunity against visceral leishmaniasis
Ajay Amit, Rajesh Chaudhary, Anupam Yadav, et al.
Experimental Parasitology
|
May 15, 2012
Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection
Sanjiva Bimal, Sukrat Sinha, Shubhankar K Singh, et al.
Tropical Medicine & International Health : TM & IH
|
November 10, 2012
Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial
Shyam Sundar, Prabat Sinha, T K Jha, et al.
Frontiers in Immunology
|
January 10, 2018
Identification of Potential MHC Class-II-Restricted Epitopes Derived from <i>Leishmania donovani</i> Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis
Manas Ranjan Dikhit, Akhilesh Kumar, Sushmita Das, et al.
Page
of 6